At the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in ...

Infection with Japanese encephalitis virus, a mosquito-borne flavivirus, was identified in a patient who received a liver ...

As India’s healthcare landscape evolves with cutting-edge diagnostic solutions, Chennai is set to witness a transformative development in screening with the lauching of Mispa i60 that offers a simple ...

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss?

Neuberg Diagnostics has introduced the Mispa i60 in Chennai for Alzheimer’s screening through a blood test. The test uses a ...

Phase 2 TBCRC049 trial results show tucatinib triplet therapy improves survival in HER2+ breast cancer patients with ...

A new class of biomarker tests are able to diagnose some Alzheimer's cases. The next step would be predicting it: Here's ...

An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...

Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.

Scientists have discovered a new quantitative biomarker in lumbar fluid that is helping doctors to diagnose Parkinson's ...

Health economics analysis highlights the economic burden of late-stage leptomeningeal metastases (LM) and the potential value ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) ...